Ovid Therapeutics
OVID
OVID
69 hedge funds and large institutions have $135M invested in Ovid Therapeutics in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% more capital invested
Capital invested by funds: $99.8M → $135M (+$34.7M)
15% more funds holding
Funds holding: 60 → 69 (+9)
3.3% more ownership
Funds ownership: 54.85% → 58.15% (+3.3%)
Holders
69
Holding in Top 10
2
Calls
$116K
Puts
$5K
Top Buyers
| 1 | +$8.8M | |
| 2 | +$2.74M | |
| 3 | +$2.34M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$947K |
Top Sellers
| 1 | -$5.1M | |
| 2 | -$3.24M | |
| 3 | -$761K | |
| 4 |
Millennium Management
New York
|
-$704K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$690K |